1. Home
  2. SUNS vs SGMO Comparison

SUNS vs SGMO Comparison

Compare SUNS & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$9.23

Market Cap

124.1M

Sector

Real Estate

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.41

Market Cap

135.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUNS
SGMO
Founded
2023
1995
Country
United States
United States
Employees
N/A
183
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.1M
135.1M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
SUNS
SGMO
Price
$9.23
$0.41
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$13.00
$5.60
AVG Volume (30 Days)
138.6K
4.2M
Earning Date
03-05-2026
11-06-2025
Dividend Yield
12.97%
N/A
EPS Growth
1112.46
N/A
EPS
1.09
N/A
Revenue
$19,384,703.00
$32,875,000.00
Revenue This Year
$175.51
N/A
Revenue Next Year
$63.46
N/A
P/E Ratio
$8.48
N/A
Revenue Growth
2540.16
N/A
52 Week Low
$7.80
$0.38
52 Week High
$14.29
$1.40

Technical Indicators

Market Signals
Indicator
SUNS
SGMO
Relative Strength Index (RSI) 41.69 38.99
Support Level $9.05 $0.43
Resistance Level $9.39 $0.48
Average True Range (ATR) 0.26 0.03
MACD -0.04 0.00
Stochastic Oscillator 27.92 8.32

Price Performance

Historical Comparison
SUNS
SGMO

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: